Literature DB >> 24118438

Electronic fetal heart rate monitoring in five fetuses with Ebstein's anomaly.

Mamoru Morikawa1, Daisuke Endo, Takahiro Yamada, Kazutoshi Cho, Takashi Yamada, Hisanori Minakami.   

Abstract

AIM: It is not clear whether fetuses with Ebstein's anomaly are likely to show abnormalities on electronic fetal heart rate (FHR) monitoring during labor.
METHODS: We performed retrospective analysis of FHR monitoring results obtained between 2.5 and 0.5 h prior to delivery in all of five fetuses prenatally diagnosed as having Ebstein's anomaly and born at our institution during the period between March 2005 and July 2011. All five mothers attempted to give birth vaginally. The results of FHR monitoring in 100 consecutive women with otherwise healthy singletons who attempted vaginal delivery were included as controls.
RESULTS: The absence of FHR acceleration (4/5 [80%]), decreased baseline FHR variability (3/5 [60%]) and late deceleration (4/5 [80%]) were seen significantly more often in the five fetuses with Ebstein's anomaly than the 100 fetuses born to control women (6.0%, 6.0%, and 10%, respectively).
CONCLUSION: Fetuses with Ebstein's anomaly during labor were likely to exhibit absent acceleration, decreased baseline FHR variability and late deceleration compared to infants without cardiac structural anomalies.
© 2013 The Authors. Journal of Obstetrics and Gynaecology Research © 2013 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  Ebstein's anomaly; cardiotocography; prenatal diagnosis

Mesh:

Year:  2013        PMID: 24118438     DOI: 10.1111/jog.12190

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  1 in total

1.  Timing and Mode of Delivery in Prenatally Diagnosed Congenital Heart Disease- an Analysis of Practices within the University of California Fetal Consortium (UCfC).

Authors:  Shabnam Peyvandi; Tina Ahn Thu Thi Nguyen; Myriam Almeida-Jones; Nina Boe; Laila Rhee; Tracy Anton; Mark Sklansky; Maryam Tarsa; Gary Satou; Anita J Moon-Grady
Journal:  Pediatr Cardiol       Date:  2017-01-11       Impact factor: 1.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.